STTR Phase I: A Multimodal Integrated System For Improved Cardiopulmonary Resuscitation

STTR 第一阶段：用于改善心肺复苏的多模式集成系统

• 批准号: 2151541
• 负责人: Norman Paradis
• 金额: $ 25.6万
• 依托单位: CPR THERAPEUTICS INC.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2151541&HistoricalAwards=false
• 关键词: STTR; Phase; Multimodal; Integrated; System

This SBIR Phase I project aims to improve the outcomes of patients suffering sudden cardiac arrest. Approximately 650,000 cardiac arrests occur each year, representing the top reason for mortality and morbidity in the US and an estimated $33 billion a year for out-of-hospital costs. Overall survival remains generally below 10%, and patients are often left with significant neurological injury. Manual cardiopulmonary resuscitation (CPR) still remains one of the most effective treatments, resulting in better outcomes than current technologies. This project will develop a novel medical device that provides a novel superior automated CPR therapeutic system. It combines multiple methods of mechanical chest compression to improve patient blood flow during resuscitation.This project will advance preclinical research for developing the first clinically effective noninvasive automated CPR device. The system integrates a multimodal approach for delivering mechanical CPR, and therefore represents a significant advancement to current systems that only deliver a single mode of CPR. The automated and programmable prototype will determine the optimal combination of methods and timing, to control multiple pump mechanisms for applying mechanical chest compressions to improve patient outcomes. This Phase I project will conduct optimization studies in a swine model of cardiac arrest and develop a proof-of-concept model. These results will provide the foundation for the next generation system suitable for human use, as well as advance research results on the hemodynamic interactions of pump mechanisms and cardiac electrophysiology during CPR.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

该 SBIR 第一阶段项目旨在改善心脏骤停患者的预后。每年大约发生 650,000 例心脏骤停，这是美国死亡率和发病率的首要原因，每年的院外费用估计为 330 亿美元。总生存率普遍低于 10%，并且患者常常会留下严重的神经损伤。手动心肺复苏 (CPR) 仍然是最有效的治疗方法之一，其结果比现有技术更好。该项目将开发一种新型医疗设备，提供新型卓越的自动化心肺复苏治疗系统。它结合了机械胸部按压的多种方法，以改善复苏期间患者的血流量。该项目将推进临床前研究，以开发第一个临床上有效的无创自动心肺复苏设备。该系统集成了用于提供机械心肺复苏的多模式方法，因此代表了对仅提供单一模式心肺复苏的当前系统的重大进步。自动化和可编程原型将确定方法和时间的最佳组合，以控制多个泵机制，以应用机械胸外按压来改善患者的治疗效果。该第一阶段项目将在猪心脏骤停模型中进行优化研究，并开发概念验证模型。这些成果将为下一代适合人类使用的系统奠定基础，并推进心肺复苏过程中泵机制和心脏电生理学的血流动力学相互作用的研究成果。该奖项反映了 NSF 的法定使命，经评估认为值得支持利用基金会的智力优势和更广泛的影响审查标准。